These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2849357)

  • 1. Neurotensin and the mesocorticolimbic dopamine system.
    Bissette G; Nemeroff CB
    Ann N Y Acad Sci; 1988; 537():397-404. PubMed ID: 2849357
    [No Abstract]   [Full Text] [Related]  

  • 2. Behavioral evidence for differential neuropeptide modulation of the mesolimbic dopamine system.
    Kelley AE; Cador M
    Ann N Y Acad Sci; 1988; 537():415-34. PubMed ID: 2462397
    [No Abstract]   [Full Text] [Related]  

  • 3. Enkephalin modulation of A10 dopamine neurons: a role in dopamine sensitization.
    Kalivas PW; Duffy P; Dilts R; Abhold R
    Ann N Y Acad Sci; 1988; 537():405-14. PubMed ID: 3059934
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions between mesolimbic dopamine neurons, cholecystokinin, and neurotensin: evidence using in vivo voltammetry.
    Phillips AG; Blaha CD; Fibiger HC; Lane RF
    Ann N Y Acad Sci; 1988; 537():347-61. PubMed ID: 3059931
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neurotensin/dopamine interactions].
    Kitabgi P; Hervé D; Studler JM; Tramu G; Rostène W; Tassin JP
    Encephale; 1989; 15 Spec No():91-4. PubMed ID: 2545433
    [No Abstract]   [Full Text] [Related]  

  • 6. Mesocorticolimbic dopamine systems and reward.
    Fibiger HC; Phillips AG
    Ann N Y Acad Sci; 1988; 537():206-15. PubMed ID: 3059924
    [No Abstract]   [Full Text] [Related]  

  • 7. Involvement of mesocorticolimbic dopaminergic systems in emotional states.
    Bertolucci-D'Angio M; Serrano A; Driscoll P; Scatton B
    Prog Brain Res; 1990; 85():405-16; discussion 416-7. PubMed ID: 2094907
    [No Abstract]   [Full Text] [Related]  

  • 8. Facilitation of brain stimulation reward by mesencephalic injections of neurotensin-(1-13).
    Rompré PP; Bauco P; Gratton A
    Eur J Pharmacol; 1992 Feb; 211(3):295-303. PubMed ID: 1319909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioural and biochemical consequences of persistent overstimulation of mesolimbic dopamine systems in the rat.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1982 Apr; 21(4):327-35. PubMed ID: 7201088
    [No Abstract]   [Full Text] [Related]  

  • 10. The current status of neurotensin-dopamine interactions. Issues and speculations.
    Deutch AY; Zahm DS
    Ann N Y Acad Sci; 1992; 668():232-52. PubMed ID: 1361115
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain.
    Herve D; Tassin JP; Studler JM; Dana C; Kitabgi P; Vincent JP; Glowinski J; Rostene W
    Proc Natl Acad Sci U S A; 1986 Aug; 83(16):6203-7. PubMed ID: 3016745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adaptive responsiveness of some central receptors to the denervation of heterologous afferent fibers: functional significance and possible behavioral consequences.
    Tassin JP; Hervé D; Simon H; Taghzouti K; Rostène W; Kitabgi P; Glowinski J
    J Recept Res; 1987; 7(1-4):435-65. PubMed ID: 3040982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the dopaminergic mesocorticolimbic system necessary for intracranial self-stimulation? Biochemical and behavioral studies from A10 cell bodies and terminals.
    Simon H; Stinus L; Tassin JP; Lavielle S; Blanc G; Thierry AM; Glowinski J; Le Moal M
    Behav Neural Biol; 1979 Oct; 27(2):125-45. PubMed ID: 508212
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of mesolimbic dopaminergic behaviors by cholecystokinin.
    Crawley JN
    Ann N Y Acad Sci; 1988; 537():380-96. PubMed ID: 3059933
    [No Abstract]   [Full Text] [Related]  

  • 15. The neurobiology of neurotensin: focus on neurotensin-dopamine interactions.
    Kasckow J; Nemeroff CB
    Regul Pept; 1991 Oct; 36(2):153-64. PubMed ID: 1666685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between neuropeptides and dopamine neurons in the ventromedial mesencephalon.
    Kalivas PW
    Neurosci Biobehav Rev; 1985; 9(4):573-87. PubMed ID: 2417173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mesocorticolimbic dopamine system.
    Ann N Y Acad Sci; 1988; 537():1-540. PubMed ID: 3202542
    [No Abstract]   [Full Text] [Related]  

  • 18. Intracerebral transplantation of dopamine neurons: understanding the functional role of the mesolimbocortical dopamine system and developing a therapy for Parkinson's disease.
    Brundin P; Strecker RE; Gage FH; Lindvall O; Björklund A
    Ann N Y Acad Sci; 1988; 537():148-60. PubMed ID: 3059921
    [No Abstract]   [Full Text] [Related]  

  • 19. Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system.
    Lambert PD; Gross R; Nemeroff CB; Kilts CD
    Ann N Y Acad Sci; 1995 May; 757():377-89. PubMed ID: 7611695
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurotensin: role in psychiatric and neurological diseases.
    Cáceda R; Kinkead B; Nemeroff CB
    Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.